US 12215320
Compositions and methods for gene editing by targeting transferrin
granted A61KA61K35/407A61K48/0008
Quick answer
US patent 12215320 (Compositions and methods for gene editing by targeting transferrin) held by CRISPR THERAPEUTICS AG expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/407, A61K48/0008, A61K48/005